Netherlands Insider Trading Transactions
Latest insider transactions reported to the AFM
Showing 6701 – 6750 of 7,475 transactions
| Issuer | Insider | Position | Transaction | Price | Volume | Transaction Date | Trading Venue | Details |
|---|---|---|---|---|---|---|---|---|
| Ferrari N.V. | Picca Piccon | Chief Financial Officer | Verwerving | EUR 0.00 | EUR 0.00 | 13 Mar 2025 | OTC | |
| Universal Music Group N.V. | Pershing Square International, Ltd. | Non-Executive Director of Universal Music Group | Vervreemding | EUR 26.55 | EUR 36,606,901.05 | 13 Mar 2025 | OTC | |
| Ferrari N.V. | Manzoni F. | Chief Designer Officer | Verwerving | EUR 0.00 | EUR 0.00 | 13 Mar 2025 | OTC | |
| Universal Music Group N.V. | Pershing Square, L.P. | Non-Executive Director of Universal Music Group | Vervreemding | EUR 26.55 | EUR 140,478,864.30 | 13 Mar 2025 | OTC | |
| Pluxee N.V. | Bellon S.A. | Non-executive Director, also associated with Nathalie Bellon-Szabo and François-Xavier Bellon | Verwerving | EUR 21.68 | EUR 1,908,772.24 | 13 Mar 2025 | EURONEXT - EURONEXT AMSTERDAM | |
| Universal Music Group N.V. | Gerson J. | Chairman & CEO for Universal Music Publishing Group | Vervreemding | EUR 27.91 | EUR 697,750.00 | 13 Mar 2025 | EURONEXT - EURONEXT AMSTERDAM | |
| Ferrari N.V. | Fulgenzi G. | Chief Product Development Officer | Vervreemding | EUR 414.00 | EUR 390,816.00 | 13 Mar 2025 | EURONEXT GROWTH MILAN | |
| Pluxee N.V. | Bellon | Non-executive Director, also associated with Nathalie Bellon-Szabo and François-Xavier Bellon | Verwerving | EUR 22.27 | EUR 337,613.20 | 12 Mar 2025 | EURONEXT - EURONEXT AMSTERDAM | |
| Pluxee N.V. | Bellon | Non-executive Director, also associated with Nathalie Bellon-Szabo and François-Xavier Bellon | Verwerving | EUR 22.27 | EUR 337,613.20 | 12 Mar 2025 | EURONEXT - EURONEXT AMSTERDAM | |
| Pharming Group N.V. | Breidenbach A. | Chief Business Officer | Verwerving | EUR 0.00 | EUR 0.00 | 12 Mar 2025 | OTC | |
| Icecat N.V. | Icecat International B.V. | CEO van Icecat NV | Verwerving | EUR 10.00 | EUR 1,000.00 | 12 Mar 2025 | NPEX | |
| Pharming Group N.V. | Outersterp, van R. | Chief Ethics & Compliance Officer | Verwerving | EUR 0.00 | EUR 0.00 | 12 Mar 2025 | OTC | |
| Pluxee N.V. | Bellon S.A. | Non-executive Director, also associated with Nathalie Bellon-Szabo and François-Xavier Bellon | Verwerving | EUR 22.27 | EUR 337,613.20 | 12 Mar 2025 | EURONEXT - EURONEXT AMSTERDAM | |
| Pharming Group N.V. | Sanders M. | Chief Operations Officer | Verwerving | EUR 0.00 | EUR 0.00 | 12 Mar 2025 | OTC | |
| Pharming Group N.V. | Wakkerman J. | Chief Financial Officer | Vervreemding | EUR 0.00 | EUR 0.00 | 12 Mar 2025 | OTC | |
| Pharming Group N.V. | Relan A. | Chief Medical Officer | Verwerving | EUR 0.00 | EUR 0.00 | 12 Mar 2025 | OTC | |
| Pharming Group N.V. | Toor S. | Chief Commercial Officer | Verwerving | EUR 0.00 | EUR 0.00 | 12 Mar 2025 | OTC | |
| Pharming Group N.V. | Breidenbach A. | Chief Business Officer | Vervreemding | EUR 0.00 | EUR 0.00 | 12 Mar 2025 | OTC | |
| Pharming Group N.V. | Outersterp, van R. | Chief Ethics & Compliance Officer | Vervreemding | EUR 0.00 | EUR 0.00 | 12 Mar 2025 | OTC | |
| Pharming Group N.V. | Sanders M. | Chief Operations Officer | Vervreemding | EUR 0.00 | EUR 0.00 | 12 Mar 2025 | OTC | |
| Pharming Group N.V. | Wakkerman J. | Chief Financial Officer | Vervreemding | EUR 0.00 | EUR 0.00 | 12 Mar 2025 | OTC | |
| Pharming Group N.V. | Relan A. | Chief Medical Officer | Vervreemding | EUR 0.00 | EUR 0.00 | 12 Mar 2025 | OTC | |
| Pharming Group N.V. | Toor S. | Chief Commercial Officer | Vervreemding | EUR 0.00 | EUR 0.00 | 12 Mar 2025 | OTC | |
| Pharming Group N.V. | Breidenbach A. | Chief Business Officer | Verwerving | EUR 0.00 | EUR 0.00 | 12 Mar 2025 | OTC | |
| Icecat N.V. | Icecat International B.V. | CEO van Icecat NV | Verwerving | EUR 10.00 | EUR 1,000.00 | 12 Mar 2025 | NPEX | |
| Pharming Group N.V. | Outersterp, van R. | Chief Ethics & Compliance Officer | Verwerving | EUR 0.00 | EUR 0.00 | 12 Mar 2025 | OTC | |
| Pluxee N.V. | Bellon S.A. | Non-executive Director, also associated with Nathalie Bellon-Szabo and François-Xavier Bellon | Verwerving | EUR 22.27 | EUR 337,613.20 | 12 Mar 2025 | EURONEXT - EURONEXT AMSTERDAM | |
| Pharming Group N.V. | Sanders M. | Chief Operations Officer | Verwerving | EUR 0.00 | EUR 0.00 | 12 Mar 2025 | OTC | |
| Pharming Group N.V. | Wakkerman J. | Chief Financial Officer | Vervreemding | EUR 0.00 | EUR 0.00 | 12 Mar 2025 | OTC | |
| Pharming Group N.V. | Relan A. | Chief Medical Officer | Verwerving | EUR 0.00 | EUR 0.00 | 12 Mar 2025 | OTC | |
| Pharming Group N.V. | Toor S. | Chief Commercial Officer | Verwerving | EUR 0.00 | EUR 0.00 | 12 Mar 2025 | OTC | |
| Pluxee N.V. | Bellon | Non-executive Director, also associated with Nathalie Bellon-Szabo and François-Xavier Bellon | Verwerving | EUR 22.24 | EUR 556,000.00 | 11 Mar 2025 | EURONEXT - EURONEXT AMSTERDAM | |
| Pluxee N.V. | Bellon | Non-executive Director, also associated with Nathalie Bellon-Szabo and François-Xavier Bellon | Verwerving | EUR 22.24 | EUR 556,000.00 | 11 Mar 2025 | EURONEXT - EURONEXT AMSTERDAM | |
| Coca-Cola Europacific Partners plc | Lusk S. | Chief Commercial Officer | Vervreemding | USD 80.95 | USD 802,376.40 | 11 Mar 2025 | NASDAQ - ALL MARKETS | |
| Coca-Cola Europacific Partners plc | Callol A. | General Manager, Iberian Business Unit | Vervreemding | USD 81.67 | USD 323,658.21 | 11 Mar 2025 | NASDAQ - ALL MARKETS | |
| Coca-Cola Europacific Partners plc | Wardle C. | General Counsel & Company Secretary | Vervreemding | USD 82.63 | USD 800,436.81 | 11 Mar 2025 | NASDAQ - ALL MARKETS | |
| Coca-Cola Europacific Partners plc | Walker E. | Chief Financial Officer | Vervreemding | USD 80.95 | USD 161,900.00 | 11 Mar 2025 | NASDAQ - ALL MARKETS | |
| Pluxee N.V. | Bellon S.A. | Non-executive Director, also associated with Nathalie Bellon-Szabo and François-Xavier Bellon | Verwerving | EUR 22.24 | EUR 556,000.00 | 11 Mar 2025 | EURONEXT - EURONEXT AMSTERDAM | |
| Coca-Cola Europacific Partners plc | Echeverría J.A. | Chief Customer Service and Supply Chain Officer | Vervreemding | USD 80.91 | USD 364,095.00 | 11 Mar 2025 | NASDAQ - ALL MARKETS | |
| Robeco Umbrella Fund I N.V. | Zwanenburg A. | Portfolio Manager | Verwerving | EUR 212.48 | EUR 2,360.65 | 11 Mar 2025 | OTC | |
| Coca-Cola Europacific Partners plc | West P. | General Manager, Australia, Pacific and Indonesia Business Unit | Vervreemding | USD 81.98 | USD 1,965,142.58 | 11 Mar 2025 | NASDAQ - ALL MARKETS | |
| Coca-Cola Europacific Partners plc | Moorhouse S. | General Manager, Great Britain | Vervreemding | USD 80.97 | USD 404,850.00 | 11 Mar 2025 | NASDAQ - ALL MARKETS | |
| Universal Music Group N.V. | Flageul P. | Executive Vice President, Controller | Vervreemding | EUR 27.26 | EUR 951,237.70 | 11 Mar 2025 | EURONEXT - EURONEXT AMSTERDAM | |
| Coca-Cola Europacific Partners plc | Wardle C. | General Counsel & Company Secretary | Vervreemding | USD 0.00 | USD 0.00 | 11 Mar 2025 | NASDAQ - ALL MARKETS | |
| Coca-Cola Europacific Partners plc | Wardle C. | General Counsel & Company Secretary | Verwerving | USD 0.00 | USD 0.00 | 11 Mar 2025 | NASDAQ - ALL MARKETS | |
| Coca-Cola Europacific Partners plc | Lusk S. | Chief Commercial Officer | Vervreemding | USD 80.95 | USD 802,376.40 | 11 Mar 2025 | NASDAQ - ALL MARKETS | |
| Coca-Cola Europacific Partners plc | Callol A. | General Manager, Iberian Business Unit | Vervreemding | USD 81.67 | USD 323,658.21 | 11 Mar 2025 | NASDAQ - ALL MARKETS | |
| Coca-Cola Europacific Partners plc | Wardle C. | General Counsel & Company Secretary | Vervreemding | USD 82.63 | USD 800,436.81 | 11 Mar 2025 | NASDAQ - ALL MARKETS | |
| Coca-Cola Europacific Partners plc | Walker E. | Chief Financial Officer | Vervreemding | USD 80.95 | USD 161,900.00 | 11 Mar 2025 | NASDAQ - ALL MARKETS | |
| Pluxee N.V. | Bellon S.A. | Non-executive Director, also associated with Nathalie Bellon-Szabo and François-Xavier Bellon | Verwerving | EUR 22.24 | EUR 556,000.00 | 11 Mar 2025 | EURONEXT - EURONEXT AMSTERDAM |